ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,264, issued on Nov. 4, was assigned to Natera Inc. (San Carlos, Calif.) and UCL Business PLC (London).
"Method of detecting tumour recurrence" was invented by Robert Charles Swanton (London) and Christopher Abbosh (Herts, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to subject-specific methods for detecting recurrence of tumours based on an understanding of the clonal/subclonal mutation profile of the subject's tumour and detection of the mutations in their cell-free DNA (cfDNA), typically by multiplex PCR of tumour mutations such as single nucleotide variants (SNVs)."
The patent was filed on Nov. 1, 2017, under...